For example, Gabbay et al. conducted a trial with 38 newly diagnosed T1D patients in Brazil which demonstrated that daily cholecalciferol (2000 IU) slowed the decline in C-peptide levels, with no adverse effects when used alongside insulin therapy [75]. The gene discussed is INS; the disease is type 1 diabetes mellitus.